Business Context and Reporting Period
This Form 8-K was filed by Artelo Biosciences, Inc. on November 14, 2019. The report serves as a Regulation FD disclosure regarding an upcoming investor presentation by the company's President and CEO, Gregory D. Gorgas.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report regarding a corporate event and does not contain financial statements or performance data.
Material Changes
No material financial changes versus a prior comparable period are reported in this filing. The document solely announces a scheduled presentation event.
Guidance, Outlook, and Management Commentary
- Upcoming Event: CEO Gregory D. Gorgas is scheduled to present at the Annual Investival Showcase on November 19, 2019, at the Waldorf Hilton Hotel in London, England.
- Timing: The presentation is set for 11:30 a.m. GMT.
- Materials: The CEO will utilize an updated slide presentation during the conference and in separate sessions with analysts and investors.
- Exhibit: The updated investor presentation is attached as Exhibit 99.1 and incorporated by reference.
Key Facts for Investor Verification
- Verify the content of the updated investor presentation attached as Exhibit 99.1 for any new strategic or financial guidance.
- Confirm the date and time of the London presentation (November 19, 2019, 11:30 a.m. GMT) for potential live attendance or webcast access.
- Note that this filing contains no audited financial data; refer to the company's most recent 10-K or 10-Q for financial status.